Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0470
0.00 (0.00%)
Feb 27, 2026, 2:16 PM EST
PVCT Market Cap
PVCT has a market cap or net worth of $19.75 million as of February 27, 2026. Its market cap has decreased by -54.28% in one year.
Market Cap
19.75M
Enterprise Value
22.12M
Revenue
350.44K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since April 24, 2002, PVCT's market cap has increased from 4.32K to 19.75M, an increase of 456,937.34%. That is a compound annual growth rate of 42.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 19.59M | -16.64% |
| Dec 31, 2025 | 23.49M | -53.46% |
| Dec 31, 2024 | 50.48M | 25.33% |
| Dec 29, 2023 | 40.27M | -11.35% |
| Dec 30, 2022 | 45.43M | 96.93% |
| Dec 31, 2021 | 23.07M | -1.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIVO Bioscience | 37.60M |
| Harvard Apparatus Regenerative Technology | 31.65M |
| EOM Pharmaceuticals Holdings | 22.76M |
| Finch Therapeutics Group | 21.28M |
| Oncotelic Therapeutics | 20.25M |
| Zeo ScientifiX | 18.93M |
| Zenith Capital | 15.97M |
| Inhibitor Therapeutics | 13.81M |